在保守管理的自发冠状动脉剖析后进行抗血小板治疗
Madeline K Mahowald1, Luis Ortega-Paz2, Claudio Laudani2,3
1Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA. madeline.mahowald@jax.ufl.edu.
Journal of thrombosis and thrombolysis
|May 25, 2025
概括
自发冠状动脉剖析 (SCAD) 需要最佳的医疗治疗,但目前的抗血小板策略尚不清楚. 本综述分析了数据,并为SCAD患者的抗血小板使用提供了建议.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 干预心脏病学 干预心脏病学
背景情况:
- 自发冠状动脉解剖 (SCAD) 是急性冠状动脉综合征 (ACS) 的不常见原因.
- 对SCAD的最佳药物治疗仍然没有定义.
- 目前的治疗通常遵循斑块破裂ACS的指导方针,使用双抗血小板疗法 (DAPT).
研究的目的:
- 审查关于SCAD抗血小板治疗的现有数据.
- 分析抗血小板治疗对SCAD后主要心脏不良事件 (MACE) 的影响.
- 为保守性SCAD治疗后的抗血小板管理提供临床建议.
主要方法:
- 对SCAD抗血小板治疗的综合文献综述.
- 包括观察性研究的元分析.
- 综合证据,制定临床实践建议.
主要成果:
- 观察性研究显示,在SCAD中DAPT疗效方面有矛盾的结果.
- 支持SCAD标准DAPT的证据有限,并来自不同的ACS病因.
- 需要进一步的研究来澄清最佳的抗血小板策略.
结论:
- 目前对SCAD抗血小板治疗的建议是基于有限的证据.
- 相互矛盾的数据需要谨慎地对待SCAD中的DAPT.
- 临床实践指南应根据具体的SCAD数据和正在进行的研究进行更新.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
40
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
40
Acute Coronary Syndrome IV: Interprofessional Care
34
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
34
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
656
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
656
Peripheral Artery Disease III: Interprofessional Care
36
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
36
Angina IV: Management
34
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
34
Acute Coronary Syndrome V: Nursing Management
47
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
47


